Synovus to announce third quarter 2024 earnings results

Insider Monkey
Mizuho Initiates Coverage on Dell Technologies Inc. (DELL) with $135 Price Target, Citing Strong Position in AI Server Market Amid Generative AI Boom
We recently compiled a list of the 20 Trending AI Stocks on Latest Analyst Ratings and News. In this article, we are going to take a look at where Dell Technologies Inc. (NYSE:DELL) stands against the other AI stocks. The latest developments in the AI industry from a business perspective highlight a growing momentum, driven by […]
Insider Monkey
Do You Believe in Rubrik’s (RBRK) Growth Prospects?
ClearBridge Investments, an investment management company, released its “ClearBridge SMID Cap Growth Strategy” second quarter 2024 investor letter. A copy of the letter can be downloaded here. The Strategy underperformed its Russell 2500 Growth Index benchmark in the quarter. Although there were strong contributions from a few companies across different sectors, the underperformance relative to […]
GlobeNewswire
Falcon Oil & Gas Ltd. - Notice of Special Meeting of Shareholders and Management Information Circular
Falcon Oil & Gas Ltd. (“Falcon”) Notice of Special Meeting of Shareholders and Management Information Circular 27 September 2024 - Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) will hold a special meeting of shareholders at the Conrad Hotel, Earlsfort Terrace, Dublin 2, Ireland on 29 October 2024 at 11:00 a.m. (Dublin time). A complete notice and related documents are now available on SEDAR+ at www.sedarplus.ca and Falcon’s website at www.falconoilandgas.com and are being sent to shareholders of re
People
Prince Harry Is Keeping Princess Diana's Landmine Legacy Alive: 'He Wants to Finish the Job' (Exclusive)
The Duke of Sussex has dedicated much of his public life to continuing Princess Diana’s humanitarian legacy, particularly her groundbreaking work in Angola’s minefields
GlobeNewswire
Biopharmaceutical Market Size Projected to Reach USD 17,902.42 Billion by 2032 with 49.60% CAGR – SNS Insider
According to Research by SNS Insider, Biopharmaceutical Market Growth is Driven by Growing Demand for Chronic Disease Treatments and Biopharmaceutical Innovations.Pune, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Biopharmaceutical Market Size & Growth Analysis: According to SNS Insider, The Biopharmaceutical Market Size was valued at USD 572.33 Billion in 2023 and is expected to reach USD 17,902.42 Billion by 2032 and grow at a CAGR of 49.60% over the forecast period 2024-2032. An increasing burden of ch
GlobeNewswire
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of discloser:Invesco Ltd. (b)Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)Name of offeror/offeree in relation to whose relevant securities this
GlobeNewswire
Form 8.3 - Keywords Studios Plc
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation
Investing.com
Wall Street analysts react to Intuit analyst day
Investing.com -- Intuit's recent annual Analyst Day received positive reactions from Wall Street, with analysts highlighting the company's strategic direction, innovation in AI, and its potential to drive growth by moving upmarket.
Investor's Business Daily
Dow Jones Futures Rise After Fed Inflation Data; Costco Falls On Earnings
Stock Market Today: Dow Jones futures rose Friday morning after key Fed inflation data. Costco stock dropped on earnings.
Business Wire
Net Asset Value(s)
LONDON, September 27, 2024-- Funds
Business Wire
Form 8.3 - AngloGold Ashanti plc
LONDON, September 27, 2024-- FORM 8.3
GlobeNewswire
Form 8.3 - Balanced Commercial Property Trust Limited
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation
GlobeNewswire
Micro Fulfillment Centers (MFCs) Strategic Business Report 2024: Market to Reach $31.6 Billion by 2030, Driven by Omni-Channel Retailing, Inventory Optimization, and Preference for Same-Day Delivery
Micro Fulfillment Centers (MFCs) Market Micro Fulfillment Centers (MFCs) Market Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Micro Fulfillment Centers (MFCs) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Micro Fulfillment Centers (MFCs) was estimated at US$4.7 Billion in 2023 and is projected to reach US$31.6 Billion by 2030, growing at a CAGR of 31.4% from 2023 to 2030. This comprehensive report provides an in-depth analy
BBC
Schools and roads closed after more flooding
More heavy rain hits Bedfordshire, Buckinghamshire and Hertfordshire overnight, leading to flooding.
Investor's Business Daily
Bristol-Myers Squibb's Novel Schizophrenia Drug Wins FDA Approval; BMY Stock Set To Break Out
Bristol-Myers Squibb won FDA approval for its novel schizophrenia drug, Cobenfy. BMY stock jumped, signaling a breakout.
GlobeNewswire
Invesco Ltd: Form 8.3 - Rightmove PLC ;Public dealing disclosure
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of discloser:Invesco Ltd. (b)Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)Name of offeror/offeree in relation to whose relevant securities this
GlobeNewswire
Form 8.3 - Keywords Studios plc - Octopus Investments
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:OCTOPUS INVESTMENTS LTD(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree i
Motherly
Almost 50% of parents heading back to work after parental leave found it harder than expected, survey finds
The founder of Parentaly shares tips for a smoother return to office.
GlobeNewswire
Ensurge Micropower ASA - Registration of Share Capital Increase
Oslo, 27 September 2024 Reference is made to the announcement by Ensurge Micropower ASA (the "Company") on 19 September 2024 regarding a successful private placement of shares ("Private Placement"), through an allocation of 61,790,320 new shares in Tranche 1 and an allocation of 13,209,680 new shares in Tranche 2, for total gross proceeds (i.e. both tranches) of NOK 75 million. The share capital increase associated with Tranche 1 has now been duly registered in the Register of Business Enterpris
GlobeNewswire
Diabetes Drugs Global Strategic Business Report 2024: Market to Surpass $205 Billion by 2030 - Development of GLP-1 Receptor Agonists Expands Treatment Options
Diabetes Drugs Market Diabetes Drugs Market Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Diabetes Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Diabetes Drugs was estimated at US$110.4 Billion in 2023 and is projected to reach US$205.3 Billion by 2030, growing at a CAGR of 9.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informe

NZX 50

NZD/USD

NZD/EUR

ALL ORDS

ASX 200

OIL

GOLD

NASDAQ

FTSE

Dow Jones

DAX

Hang Seng

NIKKEI 225

NZD/JPY

Synovus to announce third quarter 2024 earnings results

Latest stories

Mizuho Initiates Coverage on Dell Technologies Inc. (DELL) with $135 Price Target, Citing Strong Position in AI Server Market Amid Generative AI Boom

Do You Believe in Rubrik’s (RBRK) Growth Prospects?

Falcon Oil & Gas Ltd. - Notice of Special Meeting of Shareholders and Management Information Circular

Prince Harry Is Keeping Princess Diana's Landmine Legacy Alive: 'He Wants to Finish the Job' (Exclusive)

Biopharmaceutical Market Size Projected to Reach USD 17,902.42 Billion by 2032 with 49.60% CAGR – SNS Insider

Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure

Form 8.3 - Keywords Studios Plc

Wall Street analysts react to Intuit analyst day

Dow Jones Futures Rise After Fed Inflation Data; Costco Falls On Earnings

Net Asset Value(s)

Form 8.3 - AngloGold Ashanti plc

Form 8.3 - Balanced Commercial Property Trust Limited

Micro Fulfillment Centers (MFCs) Strategic Business Report 2024: Market to Reach $31.6 Billion by 2030, Driven by Omni-Channel Retailing, Inventory Optimization, and Preference for Same-Day Delivery

Schools and roads closed after more flooding

Bristol-Myers Squibb's Novel Schizophrenia Drug Wins FDA Approval; BMY Stock Set To Break Out

Invesco Ltd: Form 8.3 - Rightmove PLC ;Public dealing disclosure

Form 8.3 - Keywords Studios plc - Octopus Investments

Almost 50% of parents heading back to work after parental leave found it harder than expected, survey finds

Ensurge Micropower ASA - Registration of Share Capital Increase

Diabetes Drugs Global Strategic Business Report 2024: Market to Surpass $205 Billion by 2030 - Development of GLP-1 Receptor Agonists Expands Treatment Options